Studies on the cardiac actions of flosequinan in vitro
Open Access
- 1 April 1992
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 105 (4) , 985-991
- https://doi.org/10.1111/j.1476-5381.1992.tb09089.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clinical efficacy of flosequinan in heart failureAmerican Heart Journal, 1991
- Pharmacology of flosequinanAmerican Heart Journal, 1991
- Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymesTrends in Pharmacological Sciences, 1991
- Positive Inotropy Contributes to the Hemodynamic Mechanism of Action of Flosequinan (BTS 49465) in the Intact DogJournal of Cardiovascular Pharmacology, 1990
- Positive Inotropic and Hemodynamic Properties of Flosequinan, a New Vasodilator, and a Sulfone MetaboliteJournal of Cardiovascular Pharmacology, 1989
- Cardiovascular effects of the novel arteriovenous dilator agent, flosequinan in conscious dogs and catsBritish Journal of Pharmacology, 1988
- Analysis of Responses to a Selective Phosphodiesterase III Inhibitor, SK&F 94120, on Isolated Myocardium, Including Human Ventricular Myocardium from “End-Stage” Failure PatientsJournal of Cardiovascular Pharmacology, 1987
- Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failureAmerican Heart Journal, 1987
- Pharmacological studies with SK&F 94120, a novel positive inotropic agent with vasodilator activityJournal of Pharmacy and Pharmacology, 1986
- Characterization of an isolated, working guinea-pig heart including effects of histamine and noradrenalineJournal of Pharmacological Methods, 1978